Drug Type Therapeutic vaccine |
Synonyms KEY-Vaxx, PD-1 (KEY-Vaxx), PD-1 cancer vaccine + [5] |
Target |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Microsatellite instability-high colorectal cancer | Phase 2 | - | - | |
Adenocarcinoma of Lung | Phase 1 | US | 30 Nov 2020 | |
Adenocarcinoma of Lung | Phase 1 | AU | 30 Nov 2020 | |
metastatic non-small cell lung cancer | Phase 1 | US | 30 Nov 2020 | |
metastatic non-small cell lung cancer | Phase 1 | AU | 30 Nov 2020 | |
Non-small cell lung cancer stage IIIB | Phase 1 | US | 30 Nov 2020 | |
Non-small cell lung cancer stage IIIB | Phase 1 | AU | 30 Nov 2020 | |
Squamous non-small cell lung cancer | Phase 1 | US | 30 Nov 2020 | |
Squamous non-small cell lung cancer | Phase 1 | AU | 30 Nov 2020 | |
undifferentiated large cell lung cancer | Phase 1 | US | 30 Nov 2020 |
Not Applicable | - | 43 | PD-1 inhibitor | chvcgwrqwb(zwhywhfuei) = csmswzzzjc ijwnoksfma (clatopdevx ) View more | - | 06 Aug 2022 | |
PD-L1 inhibitor | chvcgwrqwb(zwhywhfuei) = dicmbpnmzl ijwnoksfma (clatopdevx ) View more | ||||||
Phase 1 | 4 | jakgyjzltn(udcwocwqpu) = no observed eeraavumnn (laqqcuhtit ) | Positive | 02 Jun 2022 | |||
Not Applicable | 29 | Chemotherapy | upjafszxts(tpsiglshna) = lekcorgswb usmcbqmjjk (hrbswemqlk ) | - | 20 May 2015 |